Bristol; David W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bristol; David W..The latest application filed is for "opioid salts with release properties and characteristics useful for abuse deterrent drug product formulations".

Company Profile

2.39.4

Bristol; David W. - Pisgah Forest NC
Bristol; David W. - Mills River NC
- Mills River NC US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features Grant 10,183,001 - King , et al. Ja	2019-01-22
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder Grant 9,226,925 - King , et al. January 5, 2	2016-01-05
Opioid Salts with Release Properties and Characteristics Useful for Abuse Deterrent Drug Product Formulations App 20150164835 - King; Clifford Riley ; et al.	2015-06-18
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder Grant 8,980,880 - King , et al. March 17, 2	2015-03-17
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder Grant 8,957,067 - King , et al. February 17, 2	2015-02-17
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder Grant 8,940,729 - King , et al. January 27, 2	2015-01-27
Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties Grant 08921386 -	2014-12-30
Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties Grant 8,921,386 - King , et al. December 30, 2	2014-12-30
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder Grant 8,916,587 - King , et al. December 23, 2	2014-12-23
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder Grant 8,912,217 - King , et al. December 16, 2	2014-12-16
Abuse-deterrent methadone for the safe treatment of drug abuse and pain relief Grant 8,846,766 - King , et al. September 30, 2	2014-09-30
Safety Of Psuedoephedrine Drug Products App 20140178480 - King; Clifford Riley ; et al.	2014-06-26
Opioid salts and formulations exhibiting anti-abuse and anti-dumping properties Grant 8,748,416 - King , et al. June 10, 2	2014-06-10
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder Grant 8,716,337 - King , et al. May 6, 2	2014-05-06
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder Grant 8,716,278 - King , et al. May 6, 2	2014-05-06
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder Grant 8,653,106 - King , et al. February 18, 2	2014-02-18
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder Grant 8,653,065 - King , et al. February 18, 2	2014-02-18
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder Grant 8,586,575 - King , et al. November 19, 2	2013-11-19
Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties Grant 8,569,329 - King , et al. October 29, 2	2013-10-29
Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties Grant 8,569,330 - King , et al. October 29, 2	2013-10-29
Opioid salts and formulations exhibiting anti-abuse and anti-dumping properties Grant 8,476,291 - King , et al. July 2, 2	2013-07-02
Opioid salts and formulations exhibiting anti-abuse anti-dose dumping properties Grant 8,367,693 - King , et al. February 5, 2	2013-02-05
Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties Grant 8,338,444 - King , et al. December 25, 2	2012-12-25
Opioid salts and formulations exhibiting abuse deterrent and anti-dose dumping properties Grant 8,329,720 - King , et al. December 11, 2	2012-12-11
Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties Grant 8,211,905 - King , et al. July 3, 2	2012-07-03
Abuse Deterrent And Anti-dose Dumping Pharmaceutical Salts Useful For The Treatment Of Attention Deficit/hyperactivity Disorder App 20120028960 - King; Clifford Riley ; et al.	2012-02-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.